女性用性的欲求低下障害治療薬の世界市場 2020年

• 英文タイトル：Global Female Hypoactive Sexual Desire Disorder Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201114425 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、女性用性的欲求低下障害治療薬の世界市場を調査対象にし、女性用性的欲求低下障害治療薬の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（BP-101、ブレメラノチド、ゲピロン塩酸塩ER、PVT-011、その他）、用途別分析（外来患者、入院患者）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Emotional Brain BV、Pivot Pharmaceuticals Inc、GlaxoSmithKline Plc、Palatin Technologies Inc、Strategic Science & Technologies LLC ・企業別売上、市場シェア ・女性用性的欲求低下障害治療薬の地域別市場分析 ・女性用性的欲求低下障害治療薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・女性用性的欲求低下障害治療薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・女性用性的欲求低下障害治療薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・女性用性的欲求低下障害治療薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・女性用性的欲求低下障害治療薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・女性用性的欲求低下障害治療薬の種類別市場規模2015-2020：BP-101、ブレメラノチド、ゲピロン塩酸塩ER、PVT-011、その他 ・女性用性的欲求低下障害治療薬の用途別市場規模2015-2020：外来患者、入院患者 ・女性用性的欲求低下障害治療薬の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Female Hypoactive Sexual Desire Disorder Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Female Hypoactive Sexual Desire Disorder Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Female Hypoactive Sexual Desire Disorder Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Female Hypoactive Sexual Desire Disorder Therapeutics market has been segmented into:
BP-101
Bremelanotide
Gepirone Hydrochloride ER
PVT-011
Others

By Application, Female Hypoactive Sexual Desire Disorder Therapeutics has been segmented into:
Out-Patient
In-Patient

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Female Hypoactive Sexual Desire Disorder Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Female Hypoactive Sexual Desire Disorder Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Female Hypoactive Sexual Desire Disorder Therapeutics market.

The report offers in-depth assessment of the growth and other aspects of the Female Hypoactive Sexual Desire Disorder Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Female Hypoactive Sexual Desire Disorder Therapeutics Market Share Analysis
Female Hypoactive Sexual Desire Disorder Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Female Hypoactive Sexual Desire Disorder Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Female Hypoactive Sexual Desire Disorder Therapeutics sales, revenue and market share for each player covered in this report.

The major players covered in Female Hypoactive Sexual Desire Disorder Therapeutics are:
Emotional Brain BV
Pivot Pharmaceuticals Inc
GlaxoSmithKline Plc
Palatin Technologies Inc
Strategic Science & Technologies LLC

レポート目次

---

Table of Contents

1 Female Hypoactive Sexual Desire Disorder Therapeutics Market Overview
1.1 Product Overview and Scope of Female Hypoactive Sexual Desire Disorder Therapeutics
1.2 Classification of Female Hypoactive Sexual Desire Disorder Therapeutics by Type
1.2.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Type in 2019
1.2.3 BP-101
1.2.4 Bremelanotide
1.2.5 Gepirone Hydrochloride ER
1.2.6 PVT-011
1.2.7 Others
1.3 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market by Application
1.3.1 Overview: Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Out-Patient
1.3.3 In-Patient
1.4 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market by Regions
1.4.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Female Hypoactive Sexual Desire Disorder Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Female Hypoactive Sexual Desire Disorder Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Female Hypoactive Sexual Desire Disorder Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Female Hypoactive Sexual Desire Disorder Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Female Hypoactive Sexual Desire Disorder Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Female Hypoactive Sexual Desire Disorder Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Emotional Brain BV
2.1.1 Emotional Brain BV Details
2.1.2 Emotional Brain BV Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Emotional Brain BV SWOT Analysis
2.1.4 Emotional Brain BV Product and Services
2.1.5 Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pivot Pharmaceuticals Inc
2.2.1 Pivot Pharmaceuticals Inc Details
2.2.2 Pivot Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pivot Pharmaceuticals Inc SWOT Analysis
2.2.4 Pivot Pharmaceuticals Inc Product and Services
2.2.5 Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 GlaxoSmithKline Plc
2.3.1 GlaxoSmithKline Plc Details
2.3.2 GlaxoSmithKline Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GlaxoSmithKline Plc SWOT Analysis
2.3.4 GlaxoSmithKline Plc Product and Services
2.3.5 GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Palatin Technologies Inc
2.4.1 Palatin Technologies Inc Details
2.4.2 Palatin Technologies Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Palatin Technologies Inc SWOT Analysis
2.4.4 Palatin Technologies Inc Product and Services
2.4.5 Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Strategic Science & Technologies LLC
2.5.1 Strategic Science & Technologies LLC Details
2.5.2 Strategic Science & Technologies LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Strategic Science & Technologies LLC SWOT Analysis
2.5.4 Strategic Science & Technologies LLC Product and Services
2.5.5 Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Female Hypoactive Sexual Desire Disorder Therapeutics Players Market Share
3.2.2 Top 10 Female Hypoactive Sexual Desire Disorder Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Market Share by Regions
4.2 North America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Countries
5.1 North America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Countries (2015-2020)
5.2 USA Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Countries
6.1 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Countries
7.1 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Countries (2015-2020)
7.2 China Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Countries
8.1 South America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Female Hypoactive Sexual Desire Disorder Therapeutics by Countries
9.1 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast by Type (2019-2024)
10.3 BP-101 Revenue Growth Rate (2015-2025)
10.4 Bremelanotide Revenue Growth Rate (2015-2025)
10.5 Gepirone Hydrochloride ER Revenue Growth Rate (2015-2025)
10.6 PVT-011 Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Segment by Application
11.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast by Application (2019-2024)
11.3 Out-Patient Revenue Growth (2015-2020)
11.4 In-Patient Revenue Growth (2015-2020)
12 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Forecast (2021-2025)
12.1 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Size Forecast (2021-2025)
12.2 Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Female Hypoactive Sexual Desire Disorder Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Emotional Brain BV Corporate Information, Location and Competitors
Table 6. Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Major Business
Table 7. Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Total Revenue (USD Million) (2017-2018)
Table 8. Emotional Brain BV SWOT Analysis
Table 9. Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Product and Solutions
Table 10. Emotional Brain BV Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Pivot Pharmaceuticals Inc Corporate Information, Location and Competitors
Table 12. Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Major Business
Table 13. Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Total Revenue (USD Million) (2018-2019)
Table 14. Pivot Pharmaceuticals Inc SWOT Analysis
Table 15. Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Product and Solutions
Table 16. Pivot Pharmaceuticals Inc Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. GlaxoSmithKline Plc Corporate Information, Location and Competitors
Table 18. GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Major Business
Table 19. GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Total Revenue (USD Million) (2017-2018)
Table 20. GlaxoSmithKline Plc SWOT Analysis
Table 21. GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Product and Solutions
Table 22. GlaxoSmithKline Plc Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Palatin Technologies Inc Corporate Information, Location and Competitors
Table 24. Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Major Business
Table 25. Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Total Revenue (USD Million) (2017-2018)
Table 26. Palatin Technologies Inc SWOT Analysis
Table 27. Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Product and Solutions
Table 28. Palatin Technologies Inc Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Strategic Science & Technologies LLC Corporate Information, Location and Competitors
Table 30. Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Major Business
Table 31. Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Total Revenue (USD Million) (2017-2018)
Table 32. Strategic Science & Technologies LLC SWOT Analysis
Table 33. Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Product and Solutions
Table 34. Strategic Science & Technologies LLC Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 36. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Share by Players (2015-2020)
Table 37. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 38. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Regions (2015-2020)
Table 39. North America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Countries (2015-2020)
Table 40. North America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Countries (2015-2020)
Table 41. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 42. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 43. South America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Countries (2015-2020)
Table 44. South America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Countries (2015-2020)
Table 45. Middle East and Africa Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 46. Middle East and Africa Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Countries (2015-2020)
Table 47. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 48. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Share by Type (2015-2020)
Table 49. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Forecast by Type (2021-2025)
Table 50. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue by Application (2015-2020)
Table 51. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Share by Application (2015-2020)
Table 52. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Forecast by Application (2021-2025)
Table 53. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Female Hypoactive Sexual Desire Disorder Therapeutics Picture
Figure 2. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Type in 2019
Figure 3. BP-101 Picture
Figure 4. Bremelanotide Picture
Figure 5. Gepirone Hydrochloride ER Picture
Figure 6. PVT-011 Picture
Figure 7. Others Picture
Figure 8. Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Application in 2019
Figure 9. Out-Patient Picture
Figure 10. In-Patient Picture
Figure 11. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share in 2019
Figure 20. Global Top 10 Players Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 24. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Regions in 2018
Figure 25. North America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 26. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 28. South America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 30. North America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 31. North America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Countries in 2019
Figure 32. USA Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 33. Canada Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 35. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Countries in 2019
Figure 37. Germany Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 38. UK Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 39. France Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. Russia Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 41. Italy Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Countries in 2019
Figure 44. China Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 45. Japan Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 46. Korea Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. India Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 49. South America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 50. South America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Countries in 2019
Figure 51. Brazil Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 56. UAE Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Female Hypoactive Sexual Desire Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 59. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Share by Type (2015-2020)
Figure 60. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Share by Type in 2019
Figure 61. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share Forecast by Type (2021-2025)
Figure 62. Global BP-101 Revenue Growth Rate (2015-2020)
Figure 63. Global Bremelanotide Revenue Growth Rate (2015-2020)
Figure 64. Global Gepirone Hydrochloride ER Revenue Growth Rate (2015-2020)
Figure 65. Global PVT-011 Revenue Growth Rate (2015-2020)
Figure 66. Global Others Revenue Growth Rate (2015-2020)
Figure 67. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Share by Application (2015-2020)
Figure 68. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Share by Application in 2019
Figure 69. Global Female Hypoactive Sexual Desire Disorder Therapeutics Market Share Forecast by Application (2021-2025)
Figure 70. Global Out-Patient Revenue Growth Rate (2015-2020)
Figure 71. Global In-Patient Revenue Growth Rate (2015-2020)
Figure 72. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Forecast (2021-2025)
Figure 76. Europe Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Forecast (2021-2025)
Figure 78. South America Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Female Hypoactive Sexual Desire Disorder Therapeutics Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---